Methods and compositions for treating cancer in taxane-resistant patients
AssigneeModra Pharmaceuticals B.V.
InventorsEric VAN DER PUTTEN, Colin FREUND
Life of this patent
Estimating the term…
Abstract
Methods and compositions are provided for treating cancer in a taxane-resistant patient, comprising administering an effective dose of a taxane simultaneously or sequentially with a P-gp inhibitor, such as ritonavir or a pharmaceutically acceptable salt thereof. Also provided are methods and compositions for reversing taxane resistance in a patient, comprising administering an effective dose of a P-gp inhibitor, such as ritonavir or a pharmaceutically acceptable salt thereof.
Claims24
A method for treating cancer in a taxane-resistant patient, the method comprising administering an effective dose of a taxane simultaneously or sequentially with ritonavir or a pharmaceutically acceptable salt thereof.
A method for reversing taxane resistance in a patient, comprising administering an effective dose of ritonavir or a pharmaceutically acceptable salt thereof.
(canceled)
-53. (canceled)
A kit comprising:
- at least one pharmaceutical composition comprising a taxane;
- and
- at least one pharmaceutical composition comprising a P-gp inhibitor.
(canceled)
-60. (canceled)
Dependencies are inferred from the claim text.